Tianyin Pharmaceutical (TPI)
Tianyin Pharmaceutical Earnings Yield: 71.86%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TPI Earnings Yield Rankings
| Overall | 99th percentile | 36 of 4316 |
| Sector | 98th percentile | 6 of 494 in Healthcare |
| Industry | 97th percentile | 1 of 41 in Drug Manufacturers - Other |
TPI Earnings Yield Range, Past 5 Years
| Minimum | 8.10% | Dec 2009 |
| Maximum | 71.86% | May 31 2012 |
| Average | 26.41% |
About Earnings Yield
Earnings yield is earnings per share from the previous four quarters divided by the share price. It is the reciprocal of the P/E ratio. The earnings yield is quoted as a percentage, which illustrates the percentage of each dollar invested that was earned by the company during the past twelve months.
The earnings yield can be used to compare the earnings of a stock, sector or the whole market against bond yields. Generally, the earnings yields of equities are higher than the yield of risk-free treasury bonds. Financial theorists argue that this difference exists because stock earnings are riskier than bond coupon payments.
If a company has an earnings yield of 64%, investors are purchasing $0.64 of earnings per dollar invested.
Learn More
You may also be interested in these TPI related companies
TPI News
Tianyin Pharmaceutical's CEO Discusses F3Q12 Results - Earnings Call Transcript
May 15, 11:34AM Seeking Alpha
May 15, 11:34AM Seeking Alpha
Tianyin Pharmaceutical's Management Discusses F2Q12 Results - Earnings Call Transcript
Feb 14, 2:13PM Seeking Alpha
Feb 14, 2:13PM Seeking Alpha
TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City
Jan 24, 6:08AM PR Newswire
Jan 24, 6:08AM PR Newswire
TPI Presents at the 2nd Annual OneMed China Forum on January 9th, 2012 in San Francisco
Dec 23, 11:04AM PR Newswire
Dec 23, 11:04AM PR Newswire
Tianyin Pharmaceutical (TPI) Reports Q1 Earnings of $0.05; Guides FY11 Revs
Nov 14, 6:53AM Street Insider
Nov 14, 6:53AM Street Insider
Tianyin Pharma to develop new formulation for flagship product Gingko Mihuan
Nov 04, 5:21AM FlyOnTheWall
Nov 04, 5:21AM FlyOnTheWall
=> $TPI $1.80 TONG JAMES JIAYUAN CFO P 1,000 @ $1.89 amnt $1,890 proc'd ($90) 5/20/2011
about 375 days ago by canarionyc
about 375 days ago by canarionyc
Tianyin Pharmaceutical Co $TPI has reported Record Fiscal 2010 Financial Results. http://stk.ly/a6nP3O
about 611 days ago by BioMedReports
about 611 days ago by BioMedReports
$TPI new investor presentation from Roth's Hawaii gathering is available now (PDF) http://bit.ly/atsS0G #ChinaStocks
about 617 days ago by rames
about 617 days ago by rames
Taking a look at $CSIG, $CRR and $TPI. I like their clean balance sheets, dividends, and earnings growth.
about 669 days ago by WPThatcher
about 669 days ago by WPThatcher
Love $TPI as well RT @wsmco more for the china bubble loser crowd: my $tpi has 37% insider ownership, PE of 9 and 75 cents in cash
about 751 days ago by jflesta
about 751 days ago by jflesta
@Spartanopolis ah, $tpi got it too. fabulous earnings, all good news and sitting there dead. i will be holding for when reason returns.
about 751 days ago by wsmco
about 751 days ago by wsmco
@MilesJStoner thanks. valerie is a beyond-wonderful person. i bought $tpi at 3.64. want to see how new cfo from roth delivers.
about 779 days ago by wsmco
about 779 days ago by wsmco
@wsmco I know you are hesitant about $CSKI, I liked your $TPI video, Nice $CSKI article http://www.nextinsight.biz/content/view/...
about 780 days ago by wallstreetbean
about 780 days ago by wallstreetbean
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TPI | 0.5149 | +0.03 | +7.27% | 15.14M |
| TPGI | 4.73 | -0.01 | -0.21% | 176.75M |
| TPCG | 30.85 | -0.74 | -2.34% | 494.38M |
| TPC | 11.05 | -0.19 | -1.69% | 531.99M |
| TOWR | 11.38 | -1.28 | -10.11% | 249.15M |
| TOWN | 12.22 | -0.20 | -1.61% | 357.70M |
| TOTS | 34.10 | +0.00 | +0.00% | |
| TOT | 42.17 | -0.90 | -2.09% | 101.81B |
| TORMD | 17.14 | -0.11 | -0.63% | |
| TORM | 17.14 | -0.11 | -0.63% | 41.14M |
